This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Gross Profit stood at Rs. 36.02 crore compared to Rs. 20.42 crore during Q2FY24, a significant increase of 76.40%
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
Donation drive in São Paulo aims to support 250 young women’s health and environmental responsibility
Emraclidine was well-tolerated with an adverse event profile consistent with Phase 1b trial
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
Subscribe To Our Newsletter & Stay Updated
